Press release
Addison’s Disease Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027
The global Addison’s Disease Market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The growth of the market is mainly attributed to the increase in the prevalence of Addison’s disease, rising R&D activities to produce new drugs for diagnosis and increasing awareness about Addison’s disease among the population across the globe. The advancement in technologies and several government initiatives also played a vital role in contributing to the growth of the market. Besides, major market players such as Pfizer Inc. GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Novartis AG are adopting various strategies such as mergers & acquisition, new product launches, business expansion, and technology innovation to remain competitive in the market.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/addison-disease-market
The approvals from the FDA for the drugs produced by major market players expected to propel the growth of the market. For instance, in September 2020, Diurnal Group plc had announced that the US Food and Drug Administration (FDA) has approved Alkindi Sprinkle (hydrocortisone granules in capsules for opening). The Alkindi Sprinkle is the replacement therapy for adrenal insufficiency (AI) in infants, children and adolescents (from birth to
Media Contact:
Company name: Orion Market Research
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Addison’s Disease Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 here
News-ID: 2285927 • Views: …
More Releases from Orion Market Research
Automotive Radar Sensors Market Rising Demand and Growth Forecast Through 2033
The global automotive radar sensors market was valued at USD 6.58 billion in 2024, with projections to reach USD 32.21 billion by 2033, growing at a CAGR of 18.5% from 2025 to 2033.
🧭 Automotive Radar Sensors Market Overview
The automotive radar sensors market is experiencing significant growth, driven by the increasing demand for advanced driver-assistance systems (ADAS) and the push towards autonomous driving technologies. Radar sensors are integral to features…
Automated Passenger Counting System Market Size, Shares, Business Growth and Upc …
In 2024, the Automated Passenger Counting System Market was valued at approximately USD 10.11 billion, and it is projected to reach around USD 22.69 billion by 2033, growing at an estimated CAGR of 9.4% between 2025 and 2033.
Automated Passenger Counting System Market Overview
The Automated Passenger Counting System Market is witnessing rapid growth driven by increasing demand for real-time transit data and operational efficiency in mass transportation systems. Transit agencies and…
Digital Transformation Market Size, Shares, Business Growth and Upcoming Trends …
In 2024, the global Digital Transformation Market was valued at approximately USD 809.12 billion, and it is projected to reach around USD 3,571.67 billion by 2033, growing at an estimated CAGR of 16.01% from 2025 to 2033.
Digital Transformation Market Overview
The Digital Transformation Market is witnessing robust expansion, driven by increased investments in AI, cloud computing, IoT, and machine learning to enhance operational efficiency, agility, and customer experiences. Government and enterprise-led…
Surgical Retractors Market Size, Shares, Business Growth and Upcoming Trends For …
In 2024, the Surgical Retractors Market was valued at approximately USD 2.09 billion, and it is projected to reach about USD 3.69 billion by 2033, growing at an estimated CAGR of 6.55% from 2025 to 2033.
Surgical Retractors Market Overview
The Surgical Retractors Market is steadily expanding, propelled by rising surgical volumes driven by aging populations, the prevalence of chronic diseases, and increased demand for elective procedures. Handheld retractors remain the…
More Releases for Addison’s
Addison’s Disease Therapeutics Market Significantly Stepping towards the Succe …
Addison's disease, commonly known as adrenal insufficiency, is a rare ailment in which your body fails to create enough hormones. Your adrenal glands, which are placed directly above your kidneys, produce too little cortisol and, in some cases, too little aldosterone in Addison's disease.
Request Sample Copy of Addison’s Disease Therapeutics Market Report: https://www.infinitybusinessinsights.com/request_sample.php?id=608756
Top Key Players Included in Addison’s Disease Therapeutics Market Report:
Bristol-Myers Squibb
Merck
Novartis
Pfizer
Takeda Pharmaceutical
Bio-Techne
GlaxoSmithKline
Lupin Pharmaceuticals
Abbott
Amgen
Bayer
Biogen
Eli Lilly and Company
Boehringer Ingelheim International
Diurnal
Switzer…
Global Addison’s Disease Drugs Industry Professional Market Analysis by 2020-2 …
This report also researches and evaluates the impact of Covid-19 outbreak on the Addison’s Disease Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Addison’s Disease Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Global Addison’s Disease Drugs Market Overview:
GLOBAL INFO RESEARCH has evaluated the global Addison’s Disease Drugs market in its latest research report. The research report,…
Addison’s Disease Treatment Market: Global Markets & Advanced Technologies
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market Latest Trends & Insights 2024
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market : Trends, Opportunities and Forecasts 2024
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
Addison’s Disease Treatment Market 2024; Market shares and strategies of key p …
Addison's disease is characterized by an uncommon disorder with insufficient production of the steroid hormones known as aldosterone and cortisol from the cells of adrenal glands. Moreover, indications of Addison's disease are known as primary adrenal insufficiency, resulting from insufficient production of two hormones cortisol and aldosterone. Symptoms associated with Addison’s disease include gastrointestinal abnormalities, fatigue, and changes in skin color. Furthermore, mood changes and behavior may occur in some…
